본문으로 건너뛰기
← 뒤로

Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy.

1/5 보강
Frontiers in pharmacology 📖 저널 OA 100% 2021: 3/3 OA 2022: 12/12 OA 2023: 4/4 OA 2024: 24/24 OA 2025: 185/185 OA 2026: 100/100 OA 2021~2026 2026 Vol.17() p. 1719306
Retraction 확인
출처

Zhang M, Wang H, Pan J, Jin Y, Tan Z

📝 환자 설명용 한 줄

Colorectal cancer (CRC) remains a significant global health burden, with drug resistance, recurrence, and metastasis posing major therapeutic challenges.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Zhang M, Wang H, et al. (2026). Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy.. Frontiers in pharmacology, 17, 1719306. https://doi.org/10.3389/fphar.2026.1719306
MLA Zhang M, et al.. "Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy.." Frontiers in pharmacology, vol. 17, 2026, pp. 1719306.
PMID 41800081 ↗

Abstract

Colorectal cancer (CRC) remains a significant global health burden, with drug resistance, recurrence, and metastasis posing major therapeutic challenges. Traditional Chinese Medicine (TCM), employing a holistic "multi-component, multi-target, multi-pathway" strategy, offers a promising complementary approach. This review systematically summarizes recent advances in how TCM monomers and formulations regulate key CRC signaling pathways-including PI3K/Akt/mTOR, MAPK, Wnt/β-catenin, Hedgehog, and NF-κB-to inhibit tumor proliferation, promote apoptosis, suppress metastasis, and remodel the tumor microenvironment. Emphasis is placed on TCM's unique modulation of pathway crosstalk, providing new insights into its ability to reverse drug resistance and enhance chemosensitivity. The review further proposes and discusses the future translational potential of TCM-based "signaling network inhibitors" as an innovative strategy in CRC management.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기